Psilera Co News Today

/PRNewswire/ -- The 5th Annual Neuropsychiatric and Psychedelics Drug Development Summit will be held in Boston, MA from October 31st to November 2nd. Dr....

Psilera Bioscience Launches State-of-the-Art Computational Research of Psychedelic-Inspired Compound Library Share Article Psilera is assessing serotonin receptor activation of psychedelic drugs and novel analogues to accelerate and further validate its drug pipeline Serotonin receptor 5-HT2A (purple) crystal structure with example compound (blue ball and stick structure). This translational research is one of many ways that we are raising the bar for the development of psychedelic-based medici...